Engineering topics

Patapenka, Andrei

Publications and source records attributed to Patapenka, Andrei.

7 records

DOE OSTI2023

Modeling and Analysis Support for Acceleratro-based Production of Mo-99

NorthStar Medical Radioisotopes, LLC, is in the process of commissioning a medical isotope production facility, which will use high-power electron accelerators to produce molybdenum-99 (Mo-99), the parent of technetium-99m (Tc-99m), through photonuclear reactions in molybdenum-100 (Mo-100). In this approach, a target comprising multiple thin disks of enriched molybdenum metal is bombarded with a 40-MeV electron beam. Electrons that impinge on the molybdenum target produce bremsstrahlung x-rays that cause the nuclear reaction. Because enriched Mo-100 is expensive, there is a desire to use as much beam power as possible to achieve maximum production yield and minimize the size of the target. This requirement leads to very high beam power density (heat deposition in the target), which creates challenging requirements for target cooling. In the latest concept developed by NorthStar, a stack of target (sintered molybdenum) disks is irradiated from two sides by a 40-MeV electron beam, with a total power of 250 kW (125 kW from each side). The target disks are cooled by pressurized helium gas flowing through channels between the disks. Inconel windows in the target housing form a pressure boundary between the helium within the housing and the evacuated beam tube.

07 ISOTOPE AND RADIATION SOURCES↗

DOE OSTI2023

Simulations Supporting the Development of Northstar's Indirect Beam Parameters Monitoring System

NorthStar Medical Radioisotopes, LLC is planning to produce the important medical radioisotope molybdenum-99 (Mo-99), the parent of technetium-99m (Tc-99m), through photonuclear reactions in molybdenum-100 (Mo-100). In this approach, a target comprising multiple thin disks of enriched molybdenum metal is bombarded with a 40-MeV electron beam. Electrons impinged on the molybdenum target produce bremsstrahlung X-rays that cause the nuclear reaction. Because enriched Mo-100 is expensive, there is a desire to utilize as much beam power as possible to achieve maximum production yield and minimize the size of the target. This requirement leads to very high beam power density (and heat deposition in the target), which creates challenging requirements for the cooling of the target. The critical part of the target is the target window. It separates the high-pressure helium cooled target from the vacuum beamline and the subject of structural and thermal stress. The temperature of the target window is proportional to the energy density deposited by the beam, so it is critical to maintain the desired beam profile on the target window. The feasibility of indirectly monitoring the maximum energy density of the beam on the beam window through beam losses at the main collimator (Collimator) before the production target was verified. A model of the NorthStar beam transport line was constructed for this purpose using MAD-X and Tao/Bmad codes. Beam optics were computed for the standard operational scenario, followed by an investigation involving approximately 400 cases with parameter variations in the last tuning quadrupoles. This was done to assess the correlation between losses in the collimator and the peak energy density on the target. We developed a model to explore the potential application of Optical transition radiation (OTR) for controlling beam parameters in the NorthStar beam delivery system. This model was based on a generic formula derived from the fundamental solution of the inhomogeneous wave equation of the vector potential, and allowed us to consider various surfaces, even those with irregular or random features, using numerical integration. We applied the model to OTR generated by relativistic electrons impacting an Inconel® 718 beam window. We examined cases with different levels of the window’s surface roughness, ranging from 0.5 to 3.0 microns of root square mean (RMS) deviation. The results of the OTR simulations provided distributions of OTR photons that can be used to study the limitations of optical systems for controlling beam parameters.

43 PARTICLE ACCELERATORS↗

DOE OSTI2023

Irradiation of Mo-100 Targets and Testing Fe(ll)CI 2 Precipitation for Tc-99 Removal

The production of molybdenum-99 (Mo-99) is a critical step in the generation of technetium-99m (Tc-99m), a radioisotope widely used in medical imaging. NorthStar Medical Radioisotopes, LLC is planning to produce the important medical radioisotope Mo-99 through a photonuclear reaction on molybdenum-100 (Mo-100). Accelerator production of Mo-99 using enriched Mo-100 targets yields undesirable isotopes, such as niobium-95 (Nb-95) and zirconium-95 (Zr-95). Previous studies reported that Nb and Zr isotopes can be effectively removed from Mo-99 products through coprecipitation with Fe(III). To enable the potential utilization of the first milking of Tc-99m from a Mo-99/Tc-99m generator, it is desirable to remove long-lived Tc-99. This can be accomplished by substituting Fe(III) with Fe(II) during the precipitation step, without affecting the removal of Zr and Nb isotopes. Previous experiments demonstrated up to 99+% removal of Tc using this method. It was also observed that the presence of hydrogen peroxide significantly impacts Tc removal. This was evident in the processing of enriched Mo-100 targets, where only 25% of Tc was removed. To further investigate this, another irradiation of enriched Mo-100 disks was conducted, followed by Tc-99 removal using Fe(II). Prior to irradiation, experimental conditions for Tc removal were optimized through several test runs using Mo-100 disks spiked with Tc-99. The results of these tests are discussed in this report.

07 ISOTOPE AND RADIATION SOURCES↗

DOE OSTI2022

Irradiation of Sintered Mo Disks with Presence of Organic Impurities in He Gas Flow

Argonne National Laboratory (Argonne) is assisting NorthStar Medical Technologies in the development of a domestic supply of 99 Mo. Specifically, the present study focuses on the production of 99 Mo-feed solution used by the RadioGenix™ 99m Tc generator. During the target-irradiation phase of production, impurities can potentially be introduced into the feed, and can lead to disturbance of ligand- 99m Tc complexation chemistry and contamination of the final radiopharmaceutical that directly interacts with the patient. To address this issue, Argonne performed irradiations and chemical processing to identify whether the potential contamination of He flow with hydrocarbon oil during irradiation affects the radiochemical purity of the final K 2 MoO 4 (K 2 TcO 4 ) in 5M KOH solution. To mimic the conditions of real irradiation at NorthStar, Argonne used its electron linear accelerator and Van de Graaff facilities, heated the target and oil source to >800°C, and controlled oxygen in the presence of He during irradiation. Following irradiation, scanning electron microscopy (SEM) and carbon analysis (CA) were used to detect carbon contamination on the solid targets. The radiochemical purity of the dissolved targets was studied via thin-layer paper chromatography (TLC). As a result of these experiments, small regions of the surface of some irradiated disks were found to be high in carbon, but the total carbon content was still negligible in comparison to the reference sample, which had experienced no irradiation or contact with oil. The summarized results from the SEM, CA, and TLC tests lead to the conclusion that even an excess of oil and heating during irradiation do not affect the radiochemical purity of the final product.

38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEA↗

DOE OSTI2021

Separation and purification of Mo-99 produced from natural U 3 0 8 targets via photo-fission

The most-used medical isotope is 99m Tc (t½ = 6.0 h), which comprises over 80% of isotopes used in nuclear medicine today. It is normally derived from its transient equilibrium parent 99 Mo (t½ = 66 h). A recent surge of interest in using the more proliferation-resistant low-enriched uranium (LEU) under the American Medical Isotope Production Act (AMIPA) has presented this technical challenge: can a domestic supplier meet the estimated weekly U.S. demand of 1500 6–day Ci of 99 Mo?

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

DOE OSTI2021

Production Facility Simulations for Annular LEU Targets

Eden Radioisotopes, LLC is designing a new molybdenum-99 (Mo-99) production facility based on a TRIGA-sized reactor with a core composed of low enriched uranium (LEU) targets. Reactor production is designed to exceed U.S. demand for Mo-99 using the fission processes. The nominal operational power is 1.8MW (less than 2.0MW, to satisfy the “non-power” reactor requirement) and desired irradiation scenarios include 7, 14, or 21 days of the irradiation for each target element. Safety limits for reactor operating margins are associated with such physical phenomena as fission gas release, fuel swelling, and stress cracking. As shown in the literature, one of the critical parameters defining safety margins for metallic uranium fuel is swelling. In its turn the fuel operational temperature is the main parameter impacting the swelling rate. This report documents the results of consecutive studies of reactor criticality, fission energy depositions, and cooling conditions for the target. The maximum temperature calculated for the LEU targets allows us to choose appropriate modeling approximation of the swelling. All obtained results refer to the preliminary targets and core designs provided by Eden. A criticality analysis was performed, and the results are listed mainly to cross-check Eden’s safety report and assume maximal neutron field disturbance for maximal reactivity. A brief description of the metallic uranium swelling model is provided in the Appendix.

07 ISOTOPE AND RADIATION SOURCES↗

DOE OSTI2021

Corrosion of 347 stainless steel in the presence of uranyl sulfate solution and radiation

The U.S. molybdenum 99 (Mo-99) industry is pursuing production of fission-made Mo-99 using a uranium solution such as uranyl sulfate. In this process, uranyl sulfate solution containing low-enriched uranium will be bombarded by neutrons creating Mo-99 and other fission products. During the production, the uranyl sulfate solution will be irradiated until an acceptable activity level of Mo-99 is produced. The uranyl sulfate solution containing Mo-99 and other fission products will then undergo a series of separation steps. First, uranyl sulfate can be separated from Mo-99 using a primary titania column to recover Mo-99, with the uranyl sulfate solution to be used for another irradiation cycle. Then, raffinate from a primary titania column containing Mo-99 can be concentrated and purified using a LEU modified Cintichem process developed by Argonne National Laboratory. During irradiation, the temperature of the uranyl sulfate solution can reach near boiling (up to ~80° C assumed), causing radiolysis of water and the resultant formation of hydrogen peroxide. Because high-radiation fields will be present during each irradiation cycle, it is important to determine the corrosion rates of SS-347 under such conditions to estimate the life cycle of the target solution vessel. The buildup of corrosion products from the SS components in the uranyl sulfate solution also needs to be well understood because potential accumulation of iron, nickel, and other corrosion products may affect the Mo-99 recovery and purification process. To study the corrosion rates of SS-347 material under conditions relevant to future Mo-99 production facility, SS-347 coupons in uranyl sulfate solution at ~80° C were irradiated using Argonne’s Van de Graaff generator, which can generate high-radiation fields without fissioning of uranium or production of activation products.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗